Taiwan Oyi peptide Co. Ltd
China
Product Name: H-D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (Disulfide bond between Cys2 and Pen7)
Price: $Inquiry/1mg $Inquiry/100kg
Purity: 98.0%
Stocking Period: 1 Day
Contact: Vinnie

103429-32-9

103429-32-9 structure

Name: H-D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (Disulfide bond between Cys2 and Pen7)
Chemical Name: ctap
CAS Number: 103429-32-9
Molecular Formula: C₅₁H₆₉N₁₃O₁₁S₂
Molecular Weight: 1104.304
Catalog: Signaling Pathways GPCR/G Protein Opioid Receptor
Create Date: 2018-12-28 21:02:18
Modify Date: 2024-01-02 16:22:44
CTAP is a potent, highly selective, and brain penetrant μ opioid receptor antagonist (IC50=3.5 nM) and displays over 1200-fold selectivity over δ opioid (IC50=4500 nM) and somatostatin receptors. CTAP can be used for the study of L-DOPA-induced dyskinesia (LID)[1].

Name	ctap
Synonyms	CYS2,TYR3,ARG5,PEN7-AMIDE D-Phe-L-Cys-L-Tyr-D-Trp-L-Arg-L-Thr-L-Pen-L-Thr-NH2 M.W. 1104.30 C51H69N13O11S2 1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane-4-carboxamide, N-[(1S,2R)-1-(aminocarbonyl)-2-hydroxypropyl]-10-[3-[(aminoiminomethyl)amino]propyl]-19-[[(2R)-2-amino-1-oxo-3-phenylpropyl]amino]-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-3,3-dimethyl-6,9,12,15,18-pentaoxo-, (4R,7S,10S,13R,16S,19R)- cyclic D-Pen-Cys-Tyr-D-Trp-Arg-ThrPen-Thr-NH2 1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane-4-carboxamide, N-[(1S,2R)-1-(aminocarbonyl)-2-hydroxypropyl]-10-[3-[(aminoiminomethyl)amino]propyl]-19-[[(2R)-2-amino-1-oxo-3-phenylpropyl]amino]-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-3,3-dimethyl-6,9,12,15,18-pentaoxo-, (7S,10S,13R,16S,19R)- H-D-PHE-CYS-TYR-D-TRP-ARG-THR-PEN-THR-NH2 (7S,10S,13R,16S,19R)-N-[(2S,3R)-1-Amino-3-hydroxy-1-oxo-2-butanyl]-10-(3-carbamimidamidopropyl)-16-(4-hydroxybenzyl)-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-3,3-dimethyl-6,9,12,15,18-pentaoxo-19-(D-phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide (4R,7S,10S,13R,16S,19R)-N-[(2S,3R)-1-Amino-3-hydroxy-1-oxo-2-butanyl]-10-(3-carbamimidamidopropyl)-16-(4-hydroxybenzyl)-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-3,3-dimethyl-6,9,12,15,18-pentaoxo-19-(D-phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2

Description	CTAP is a potent, highly selective, and brain penetrant μ opioid receptor antagonist (IC50=3.5 nM) and displays over 1200-fold selectivity over δ opioid (IC50=4500 nM) and somatostatin receptors. CTAP can be used for the study of L-DOPA-induced dyskinesia (LID)[1].
Related Catalog	Signaling Pathways >> GPCR/G Protein >> Opioid Receptor Signaling Pathways >> Neuronal Signaling >> Opioid Receptor Research Areas >> Neurological Disease
Target	IC50: 3.5 nM (μ opioid receptor) IC50: 4500 nM (δ opioid receptor)[1]
References	[1]. Mitchell J Bartlett, et al. Highly-selective µ-opioid Receptor Antagonism Does Not Block L-DOPA-induced Dyskinesia in a Rodent Model.BMC Res Notes

Personal Protective Equipment	Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
Hazard Codes	Xi
RIDADR	NONH for all modes of transport
WGK Germany	3.0